Tag Archives: recurrence

Imaging for Gynecologic Oncology
4
Feb

Overview

Imaging evaluates extent nodal involvement and metastatic disease in gynecologic malignancies. Modalities include ultrasound CT MRI and PET CT. Imaging guides surgical planning and adjuvant therapy decisions.

Pelvic MRI

MRI provides superior soft tissue contrast for local staging of cervical and endometrial cancers. It assesses tumor size parametrial invasion and nodal status. Standardized reporting improves multidisciplinary communication.

PET CT Role

PET CT detects nodal and distant metastatic disease in selected gynecologic cancers. It aids in recurrence detection and treatment planning. Tracer selection and timing influence sensitivity.

Surveillance and Recurrence

Imaging protocols for surveillance depend on tumor type stage and treatment. Early detection of recurrence may influence salvage therapy options. Multidisciplinary review ensures appropriate imaging intervals and modalities.

AI for Image Based Prognostication
4
Feb

Overview

AI prognostic models predict survival recurrence and treatment response from imaging features. They support risk stratification and personalized care planning. Integration with clinical data enhances predictive accuracy.

Model Development

Training uses labeled outcomes and longitudinal follow up data. Feature selection and validation prevent overfitting and ensure generalizability. Prospective studies assess clinical impact.

Clinical Integration

Prognostic scores inform multidisciplinary decision making and patient counseling. They guide intensity of surveillance and therapeutic choices. Clear communication of uncertainty is essential.

Ethical Considerations

Prognostic models must avoid deterministic interpretations and respect patient autonomy. Transparency about model limitations and validation supports ethical use. Governance frameworks oversee deployment and monitoring.